Katharina Habenicht

ORCID: 0009-0009-4340-4172
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Immune responses and vaccinations
  • Hematopoietic Stem Cell Transplantation
  • Virus-based gene therapy research
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • Immunotherapy and Immune Responses
  • Animal Virus Infections Studies
  • Biosimilars and Bioanalytical Methods
  • Immune Response and Inflammation
  • Antimicrobial Resistance in Staphylococcus
  • Viral Infectious Diseases and Gene Expression in Insects
  • CRISPR and Genetic Engineering
  • Viral Infections and Immunology Research
  • Chronic Lymphocytic Leukemia Research

Friedrich-Alexander-Universität Erlangen-Nürnberg
2020-2025

Universitätsklinikum Erlangen
2022

Paul Ehrlich Institut
2020

The pathogenesis of severe COVID-19 reflects an inefficient immune reaction to SARS-CoV-2. Here we analyze, at the single cell level, plasmablasts egressed into blood study dynamics adaptive response in patients requiring intensive care. Before seroconversion SARS-CoV-2 spike protein, peripheral display a type 1 interferon-induced gene expression signature; however, following seroconversion, lose this signature, express instead signatures induced by IL-21 and TGF-β, produce mostly IgG1 IgA1....

10.1038/s41467-021-22210-3 article EN cc-by Nature Communications 2021-03-30

RNA vaccines are efficient preventive measures to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 antibodies an important component vaccine-induced immunity. Shortly after initial two mRNA vaccine doses, immunoglobulin G (IgG) response mainly consists proinflammatory subclasses IgG1 and IgG3. Here, we report that several months second vaccination, SARS-CoV-2–specific were increasingly composed noninflammatory IgG4,...

10.1126/sciimmunol.ade2798 article EN cc-by Science Immunology 2022-12-22

TRIANNI mice carry an entire set of human immunoglobulin V region gene segments and are a powerful tool to rapidly isolate monoclonal antibodies. After immunizing these with DNA encoding the spike protein SARS-CoV-2 boosting protein, we identified 29 hybridoma antibodies that reacted protein. Nine neutralize infection at IC50 values in subnanomolar range. ELISA-binding studies sequence analyses revealed one cluster three clonally related neutralizing target receptor-binding domain compete...

10.1002/eji.202149374 article EN cc-by-nc-nd European Journal of Immunology 2021-08-06

Abstract In clinical situations, peripheral blood accessible CD3 + CD4 CXCR5 T-follicular helper (T FH ) cells may have to serve as a surrogate indicator for dysregulated germinal center responses in tissues. To determine the heterogeneity of T versus tonsils, CD45RA – both origins were sorted. Transcriptomes, TCR repertoires and cell-surface protein expression analysed by single-cell RNA sequencing, flow cytometry immunohistochemistry. Reassuringly, all blood-circulating T-cell...

10.1038/s42003-024-06563-1 article EN cc-by Communications Biology 2024-07-18

ABSTRACT TRIANNI mice carry an entire set of human immunoglobulin V region gene segments and are a powerful tool to rapidly generate monoclonal antibodies. After immunizing these against the spike protein SARS-CoV-2, we identified 29 hybridoma antibodies that reacted with SARS-CoV-2 protein. Nine neutralized infection at IC50 values in subnanomolar range. ELISA-binding studies DNA sequence analyses revealed one cluster clonally related neutralizing target receptor-binding domain compete...

10.1101/2021.04.16.440101 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-04-16

Despite continuous exposure and development of specific immunity, Staphylococcus aureus (Sa) remains one the leading causes severe infections worldwide. Although innate immune defense mechanisms are well understood, role T cell response has not been fully elucidated. Here, we demonstrate that Sa its major virulence factors protein A (SpA) induce human regulatory cells (Tregs), key players in tolerance. In PBMC MoDC / co-cultures CD4+CD25+CD127dim Tregs were induced upon stimulation with to a...

10.3389/fimmu.2020.581713 article EN cc-by Frontiers in Immunology 2020-09-30

Abstract Here we have analyzed the dynamics of adaptive immune response triggered by SARS-CoV-2 in severely affected COVID-19 patients, as reflected activated B cells egressing into blood, at single cell level. Early on, before seroconversion to spike protein, peripheral displayed a type 1 interferon-induced gene expression signature. After seroconversion, lost this signature, expressed IL-21- and TGF-β-induced signatures, mostly IgG1 IgA1. In sustained reaction until day 59, shifted IgA2,...

10.1101/2020.09.04.20188169 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-09-08

Abstract Repeated mRNA vaccinations are an efficient tool to combat the SARS-CoV-2 pandemic. High levels of neutralizing SARS-CoV-2-antibodies important component vaccine-induced immunity. Shortly after first or second vaccine dose, IgG response mainly consists pro-inflammatory isotypes IgG1 and IgG3 is driven by T helper (Th) 1 cells. Here, we report that several months vaccination, SARS-CoV-2-specific antibodies were increasingly composed non-inflammatory IgG2 particularly IgG4, which...

10.1101/2022.07.05.22277189 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2022-07-10

The germinal center (GC) reaction is crucial for somatic hypermutation, affinity maturation, and the selection of high-affinity B cells, all which are hallmarks humoral immune response. Understanding distinct roles various cell genes essential elucidating mechanisms within GC reaction. Traditionally, studying gene function in involved generating knock-out mice, a highly time-consuming method that necessitates complex vectors. advent Clustered Regularly Interspaced Short Palindromic Repeats...

10.3389/fimmu.2024.1473760 article EN cc-by Frontiers in Immunology 2024-10-17
Coming Soon ...